Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
View ORCID ProfileChansavath Phetsouphanh, View ORCID ProfileDavid Darley, Anette Howe, View ORCID ProfileC. Mee Ling Munier, Sheila K Patel, View ORCID ProfileJenifer A Juno, View ORCID ProfileLouise M Burrell, Stephen J Kent, Gregory J Dore, Anthony D Kelleher, Gail Matthews
doi: https://doi.org/10.1101/2021.06.01.21257759
Chansavath Phetsouphanh
1The Kirby institute, University of New South Wales, NSW 2033, Australia
David Darley
2St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
Anette Howe
1The Kirby institute, University of New South Wales, NSW 2033, Australia
C. Mee Ling Munier
1The Kirby institute, University of New South Wales, NSW 2033, Australia
Sheila K Patel
3Department of Medicine, Austin Health, University of Melbourne, Victoria 3084, Australia
Jenifer A Juno
4Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Victoria 3000, Australia
Louise M Burrell
3Department of Medicine, Austin Health, University of Melbourne, Victoria 3084, Australia
Stephen J Kent
4Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Victoria 3000, Australia
5Melbourne Sexual health centre, Infectious Diseases Department, Alfred health, central Clinical School, Monash University, Melbourne, Victoria 3004, Australia
Gregory J Dore
1The Kirby institute, University of New South Wales, NSW 2033, Australia
2St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
Anthony D Kelleher
1The Kirby institute, University of New South Wales, NSW 2033, Australia
2St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
Gail Matthews
1The Kirby institute, University of New South Wales, NSW 2033, Australia
2St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
Data Availability
Source data files will be uploaded upon submission to intended journal
Posted June 03, 2021.
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh, David Darley, Anette Howe, C. Mee Ling Munier, Sheila K Patel, Jenifer A Juno, Louise M Burrell, Stephen J Kent, Gregory J Dore, Anthony D Kelleher, Gail Matthews
medRxiv 2021.06.01.21257759; doi: https://doi.org/10.1101/2021.06.01.21257759
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh, David Darley, Anette Howe, C. Mee Ling Munier, Sheila K Patel, Jenifer A Juno, Louise M Burrell, Stephen J Kent, Gregory J Dore, Anthony D Kelleher, Gail Matthews
medRxiv 2021.06.01.21257759; doi: https://doi.org/10.1101/2021.06.01.21257759
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4365)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2814)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6721)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)